Login / Signup

Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.

Mary EapenJianqun KouMartin AndreanskyMonica BhatiaJoel BrochsteinSonali ChaudhuryAnn E HaightHilary HainesDavid JacobsohnJennifer JaroscakKimberly A KasowLakshmanan KrishnamurtiJohn E LevineKathryn LeungDavid MargolisLolie C YuMary M HorowitzNaynesh KamaniMark C WaltersShalini Shenoy
Published in: American journal of hematology (2024)
Keyphrases
  • sickle cell disease
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • early onset
  • cord blood
  • cell therapy
  • open label
  • mesenchymal stem cells